MG2 FlexaLAB Laboratory Multi-Function Capsule Filler
| Brand | MG2 |
|---|---|
| Origin | Shanghai, China |
| Manufacturer Type | Authorized Distributor |
| Country of Origin | China |
| Model | FlexaLAB |
| Pricing | Available Upon Request |
Overview
The MG2 FlexaLAB Laboratory Multi-Function Capsule Filler is an engineered platform for precision capsule formulation development, clinical trial manufacturing, and low-volume commercial production. Designed by MG2 S.p.A. (Italy), it leverages the same core mechanical architecture and dosing kinematics as MG2’s high-speed industrial capsule fillers—ensuring process scalability from lab to pilot to full-scale production. The system operates on a modular, dual-mode principle: continuous or intermittent motion—selected via interchangeable drive configurations—enabling rigorous control over dwell time, tamping force, and powder densification. Its fundamental operating principle relies on synchronized cam-driven station indexing combined with programmable dosing actuation, ensuring repeatable capsule closure integrity and content uniformity across diverse dosage forms.
Key Features
- Modular multi-dosing architecture supporting simultaneous integration of up to four independent filling units—enabling true multi-component encapsulation (e.g., powder + microspheres + liquid in a single capsule shell)
- Dual-mode operation: selectable continuous or intermittent indexing to match formulation rheology, API sensitivity, and regulatory validation requirements
- Full compatibility with capsule sizes ranging from #000 to #5—including tamper-evident, elongated, HPMC, pullulan, and clinical-trial-specific shells
- Material-contact surfaces constructed entirely from electropolished AISI 316 stainless steel (per ASTM A967 and ISO 13485-compliant passivation protocols)
- Integrated containment options compliant with OEB 3–5 occupational exposure banding standards, including hard-wall isolators with glove ports and dynamic pressure cascading
- Configurable cleaning systems: from manual wet-in-place (WiP) manifolds to fully automated clean-in-place (CiP) with conductivity-based endpoint detection and thermal validation logging
Sample Compatibility & Compliance
The FlexaLAB accommodates a broad spectrum of solid and semi-solid dosage forms without requiring tooling changeovers. It supports volumetric screw feeding for free-flowing and cohesive powders; counting-based insertion for microtablets and coated pellets; vibratory micro-dosing with real-time gravimetric feedback (±0.5 mg resolution) for low-dose inhaled APIs; and precision liquid metering via peristaltic or piston-driven dispensing modules. All configurations meet material traceability and equipment qualification prerequisites under FDA 21 CFR Part 11, EU Annex 11, and ICH Q5A–Q5E guidelines. The system is pre-validated for GMP-aligned commissioning and supports IQ/OQ/PQ documentation packages aligned with ASTM E2500 and ISPE Baseline Guide Vol. 5.
Software & Data Management
Controlled via MG2’s proprietary FlexControl™ HMI (Windows Embedded OS), the system provides role-based user access, electronic batch records (EBR), and audit-trail-enabled parameter logging per ALCOA+ principles. Process data—including torque profiles, fill weight histograms, capsule ejection force curves, and environmental sensor outputs (RH, temperature, differential pressure)—are timestamped and exportable in CSV or PDF format. Optional integration with MES/SCADA platforms is supported via OPC UA 1.04 and MQTT 3.1.1 protocols. All firmware updates undergo version-controlled release verification and are documented per ISO/IEC 17025 calibration traceability requirements.
Applications
- Early-phase formulation screening for capsule-based delivery of biologics, peptides, and low-solubility compounds
- Manufacturing of comparator products and placebo capsules for blinded clinical trials (Phase I–III)
- Development of combination products: layered-release capsules, enteric-coated microspheres + immediate-release powder, or dry-powder inhaler (DPI) blends with excipient carriers
- GMP-compliant small-batch production of orphan drugs and personalized medicine doses
- Process characterization studies supporting Quality-by-Design (QbD) frameworks and Design Space definition per ICH Q8(R2)
FAQ
What capsule size ranges does the FlexaLAB support?
It handles standard gelatin and plant-based capsules from #000 to #5, including extended-length shells, tamper-evident variants, and custom clinical trial geometries.
Can the system perform real-time fill weight verification during operation?
Yes—when equipped with the optional gravimetric micro-dosing module, it delivers continuous inline weight monitoring with automatic rejection of out-of-spec capsules.
Is the FlexaLAB suitable for handling potent compounds?
Absolutely—the system integrates seamlessly with OEB 4–5-rated isolators and supports closed-transfer interfaces for API charging and capsule discharge.
Does MG2 provide validation documentation for GMP environments?
Yes—comprehensive IQ/OQ documentation kits, risk assessments (FMEA), and 21 CFR Part 11 compliance reports are available upon order confirmation.
How is software cybersecurity maintained?
FlexControl™ firmware receives quarterly security patches; network interface modules support TLS 1.2 encryption and configurable firewall rules per NIST SP 800-82.
